The Information Machine

Google DeepMind AI Co-Clinician Launch

closed · v15 · 2026-05-23 · 366 items · history

What's new in v15

The new items consist entirely of EU AI Act compliance documentation (items 12184–12188: LinkedIn compliance analysis, McKenna Consultants' healthcare-specific technical readiness guide, Tandem Health's healthcare explainer, Mondaq's legal analysis for U.S. companies, and the official EU AI Act Article 39 text) and a HealthManagement.org article on the HealthBench evaluation framework (item 12190). None contain claims, stances, or key quotes. The EU AI Act items deepen — but do not extend — the already well-documented August 2026 compliance deadline, adding healthcare-specific conformity assessment obligations to existing citations. HealthManagement.org's HealthBench coverage adds minor evidence that OpenAI's benchmark is gaining healthcare media traction. No new fault lines, perspectives, or events emerge this pass.

What

Google DeepMind announced an AI co-clinician research initiative on April 30, 2026[1], built on a 'triadic care' model and dual-agent architecture, achieving zero critical errors in 97 of 98 simulated primary care queries and matching or exceeding primary care physician performance in 68 of 140 assessed consultation skill areas. The launch arrived eight days after OpenAI launched ChatGPT for Clinicians[5] — free for verified U.S. physicians — and simultaneously released HealthBench Professional, an open benchmark claiming GPT-5.4 in the clinician workspace outperforms human physicians on clinical tasks[6][7]. Epic's Agent Factory has moved from HIMSS26 preview to confirmed deployment at Advocate Health[18], while OpenEvidence operates at a $12B valuation with documented 1 million physician-AI consultations in a single 24-hour period[12][33]. The EU AI Act's high-risk compliance deadline for medtech falls in August 2026, confirmed by multiple independent sources including healthcare-specific legal and compliance guides[25][26][27], with no public DeepMind compliance statement.

Why it matters

The clinical AI field has consolidated around an unresolved benchmark war: OpenAI has defined the evaluation terms (HealthBench Professional) while simultaneously offering a free product to physicians, Epic has moved from announcement to named health-system deployment, and DeepMind's rigorous randomized trial design may ultimately produce stronger evidence but accumulates no real-world scale in the interim. The EU compliance deadline — now extensively documented across legal, consultancy, and healthcare-specific sources — creates a concrete near-term test of whether any of these systems can meet binding regulatory requirements for patient-facing AI in the world's largest regulated healthcare market.

Open questions

  • Can DeepMind's co-clinician and OpenAI's ChatGPT for Clinicians be evaluated on a shared, independent benchmark — or will HealthBench Professional, released by OpenAI as an 'open' standard simultaneously with its own product[6][5], become the de facto industry standard on OpenAI's own terms?[10]

  • Will the Included Health nationwide randomized study[3] produce safety and efficacy data that changes deployment decisions before OpenAI and OpenEvidence accumulate orders-of-magnitude more real-world usage data?

  • Has DeepMind filed or committed to a conformity assessment path under EU AI Act Annex III for the co-clinician, given the August 2026 compliance deadline now extensively documented in healthcare-specific legal and regulatory guidance[24][25][26][27][28]?

  • Will the NEJM AI pragmatic RCT of ambient AI[29] — the first RCT-level evidence in the ambient scribing category — shift institutional adoption toward scribe-first players (Abridge, AWS HealthScribe) and away from consultation-first systems like the co-clinician that remain in trial design phase?

Narrative

On April 30, 2026, Google DeepMind published a blog post announcing the AI co-clinician, a research initiative framing AI as a participant in what it calls 'triadic care' — a three-way relationship between AI, physician, and patient[1]. The system uses a dual-agent architecture (Planner + Talker) designed to enforce safe clinical boundaries while engaging patients in real-time multimodal consultations. In benchmark testing across 98 realistic primary care scenarios, the co-clinician recorded zero critical errors in 97 cases and outperformed two widely-used physician AI tools. Across 140 assessed consultation skill areas, it matched or exceeded primary care physician performance in 68 — though expert physicians still outperformed it overall, particularly in identifying clinical red flags and guiding physical examinations[1]. The Decoder reported the co-clinician outperforms GPT-5.4 (base model) in blind physician evaluations while still trailing experienced clinicians overall[2]. Google simultaneously announced a strategic partnership with Included Health to conduct a nationwide randomized study of AI in virtual care, positioning the co-clinician as moving from benchmark performance toward structured clinical validation[3][4].

Eight days before DeepMind's announcement, on April 22, 2026, OpenAI launched ChatGPT for Clinicians — free for verified U.S. physicians, nurse practitioners, physician assistants, and pharmacists[5]. OpenAI simultaneously released HealthBench Professional, an open benchmark for evaluating large language models on real clinician chat tasks across care consultation, documentation, and medical research[6][7]. The central OpenAI claim — that GPT-5.4 in the ChatGPT for Clinicians workspace outperforms human physicians and all other models on HealthBench[5] — creates a direct benchmark conflict with DeepMind's own positioning. Physician advisors rated 99.6% of ChatGPT for Clinicians responses as safe and accurate across 6,924 tested conversations[5], while Becker's Physician Leadership covered the physician-outperformance claim directly[8] and Reddit discussions extended it into consumer discourse[9]. The two companies are using incommensurable evaluation frameworks, model versions, and physician comparison cohorts, making headline claims mutually inconsistent without independent adjudication. Critically, OpenAI released HealthBench Professional as an 'open' standard simultaneously with its own product — structurally positioning itself to define the evaluation terms the entire clinical AI field will be judged against[6]. HealthManagement.org has begun covering the HealthBench evaluation framework as a healthcare AI assessment standard[10], signaling that the benchmark is gaining traction in healthcare media beyond the initial launch coverage.

The broader competitive landscape includes several players at significantly greater deployment scale than DeepMind's research initiative. OpenEvidence, valued at $12 billion by Reuters[11], documented 1 million physician-AI clinical consultations in a single 24-hour period[12][13] and has raised $210 million at a $3.5 billion valuation while launching DeepConsult, described as 'the first AI agent purpose-built for physicians'[14]. Abridge has partnered with NEJM, JAMA, and UpToDate to embed peer-reviewed evidence directly into EHR workflows, blurring the boundary between ambient documentation and clinical decision support[15][16][17]. Epic's Agent Factory, previewed at HIMSS26 as a no-code platform for health systems to build AI agent workflows, has converted from conference preview to confirmed deployment with Advocate Health as its first named health system adopter[18][19]. Amazon launched the Amazon One Medical Health AI assistant on March 10, 2026[20], and Microsoft published a global healthcare AI transformation report on April 30 — the same day as the co-clinician announcement[21] — fragmenting the healthcare AI news cycle across simultaneous major announcements.

The regulatory and evidentiary context frames both the co-clinician's opportunity and its constraints. The AMA's 2026 Physician Survey on Augmented Intelligence found 72% of U.S. physicians now use AI in clinical practice, up from 48% the prior year[5][22][23] — establishing mainstream physician AI adoption as the backdrop against which all clinical AI products compete. The EU AI Act's Annex III high-risk classification applies to patient-facing clinical AI systems, with the August 2026 compliance deadline now extensively documented across legal, consultancy, and healthcare-specific guidance[24][25][26][27][28] — a binding regulatory forcing function that Google has not publicly addressed. Healthcare organizations face specific conformity assessment obligations under Article 39 and related provisions before placing high-risk AI systems on the EU market[28][26]. NEJM AI published what appears to be the first pragmatic randomized controlled trial of ambient artificial intelligence[29], providing RCT-level evidence for the ambient scribing category while diagnostic consultation AI — including the co-clinician — remains in trial design phase. Stanford Law's CodeX argues existing healthcare AI disclosure frameworks fail on their own terms[30], Harvard Petrie-Flom Center argues AI is redefining informed consent rules[31], and Medical Economics frames AI disclosure as an active malpractice liability question for practicing physicians[32] — converting academic debates into clinical risk management questions that apply to every system in the market.

Timeline

  • 2023: Glass Health raises $5 million in YC-backed seed funding for its AI-powered clinical decision support platform, establishing it as an early-stage competitor in the ambient scribing and CDS market. [64][68][70]
  • 2024-02: Hindustan Times reports Google DeepMind is working on an AI model to help diagnose patients, providing early public evidence the co-clinician initiative was in development at least two years before announcement. [222]
  • 2024-12-05: FDA finalizes recommendations simplifying the approval process for AI-enabled medical devices, providing a forming regulatory pathway for clinical AI systems in the US. [130]
  • 2025-04-11: Harvard Petrie-Flom Center publishes analysis arguing AI and big data are redefining informed consent rules in ways existing frameworks have not yet accommodated. [31]
  • 2026-01: ARISE (Artificial Intelligence Research Initiative in Safety and Effectiveness), led by Ethan Goh MD, publishes the Stanford-Harvard State of Clinical AI Report 2026, providing an institutional baseline assessment of the clinical AI boom and contextualizing the subsequent co-clinician launch as arriving at the documented peak of a multi-year growth curve. [108][110][109][111][112][113][114][116][117]
  • 2026-01-21: OpenEvidence doubles its valuation to $12 billion as physician adoption accelerates, confirmed by Reuters as the highest-valued named competitor in the clinical consultation AI space. [33][11]
  • 2026-02: MedCity News publishes a critical analysis arguing OpenEvidence's $12 billion valuation is unsurprising given its documented physician adoption scale — the first skeptical analytical voice on OpenEvidence's valuation in the thread. [62]
  • 2026-02-06: Epic releases native AI charting for integrated clinical documentation, entering the ambient documentation market as an EHR incumbent. [79]
  • 2026-02-20: Stanford Law School's CodeX publishes analysis arguing that existing healthcare AI disclosure frameworks — including the Mello framework — fail on their own terms when applied to AI in clinical care. [30]
  • 2026-02-27: AMA publishes National Advocacy Update and releases 2026 Physician Survey on Augmented Intelligence showing physician AI use doubled from 2023 to 2026; AMA position: physicians must lead AI tool development. [22][23][91][92][93]
  • 2026-03: Epic previews Agent Factory at HIMSS26 as a no-code platform for health systems to build configurable AI agent workflows; Advocate Health is named as the first documented health system to adopt Epic's AI Agent Factory, converting the capability from a conference preview to a confirmed real-world deployment. [81][82][83][84][85][18][19]
  • 2026-03-10: OpenEvidence announces that AI collaborated with physicians in one million clinical consultations within 24 hours, confirmed via PR Newswire and Newswise press releases; Amazon launches its healthcare AI assistant on its website and app on the same date. [51][12][20][13][61]
  • 2026-04: OpenEvidence raises $210 million at a $3.5 billion valuation and launches DeepConsult, described as 'the first AI agent purpose-built for physicians,' with a dedicated user guide published on the OpenEvidence platform. [14][58][59]
  • 2026-04: Abridge partners with NEJM, JAMA, and UpToDate for AI clinical decision-making and evidence integration, expanding from AI scribe into evidence-backed clinical decision support embedded in the EHR workflow. [71][15][72][16][73][74][75][76][17][77][78]
  • 2026-04: MedGemma 1.5 technical report published on arXiv and updated to version 4; additional YouTube and Medium coverage confirms MedGemma's CT/MRI reading and medical speech-to-text (MedASR) capabilities. [43][223][224][225][226][44][227][228][229][46][47][230][231]
  • 2026-04-22: OpenAI launches ChatGPT for Clinicians, free for verified U.S. physicians, NPs, PAs, and pharmacists, and simultaneously releases HealthBench Professional, an open benchmark for real clinician chat tasks. GPT-5.4 in the ChatGPT for Clinicians workspace claims to outperform human physicians and all other models on HealthBench; 99.6% of responses rated safe and accurate by physician advisors across 6,924 tested conversations. The launch precedes DeepMind's co-clinician announcement by eight days. [5][6][8][7][9][49][50]
  • 2026-04-30: Google DeepMind publishes AI co-clinician blog post announcing a research initiative built on a 'triadic care' model, a dual-agent (Planner + Talker) architecture, and benchmark results from 98 primary care scenarios and 140-area consultation skill assessment. The Decoder reports the co-clinician outperforms GPT-5.4 (base model) in blind doctor tests but still trails experienced physicians. [1][41][45][232][233][234][48][2]
  • 2026-04-30: On the same day as the co-clinician announcement, Microsoft publishes a global healthcare AI transformation report and Amazon introduces the Amazon One Medical Health AI assistant, fragmenting healthcare AI news coverage across four simultaneous major announcements. [119][126][21]
  • 2026-04-30: DeepMind VP Research Pushmeet Kohli, health AI leader Alan Karthikesalingam, Google Research VP Avinatan Hassidim, and Google DeepMind researcher Joëlle Barral separately publish LinkedIn posts amplifying the initiative and confirming the Included Health partnership. [34][35][36][37][4]
  • 2026-04-30: Simultaneous social media amplification across X/Twitter, LinkedIn, and Reddit; Grok (xAI) publicly comments on demo; discussion spreads to r/whitecoatinvestor and r/OpenAI communities. [206][235][236][237][238][239][240][241][242][243][244][245][246][247][248][249][250][251][252][253]
  • 2026-04: Google announces strategic partnership with Included Health for a nationwide randomized study of AI in virtual care, confirmed by multiple sources including Joëlle Barral's LinkedIn post. [38][39][208][3][209][254][4]
  • 2026-05-01: Social media amplification continues globally; YouTube Shorts coverage begins; r/medicalschool Reddit discussion emerges as the first documented medical student engagement with the co-clinician; physician Derya Unutmaz MD amplifies Alan Karthikesalingam's deep-dive analysis on X. [181][182][183][184][45][255][185][186][187][188][164][189][232]
  • 2026-05-02: International social media amplification continues with German-language coverage (KI News Daily) and accounts linking the co-clinician to Google's drug discovery initiative approaching human trials, broadening the co-clinician narrative beyond clinical consultation into pharmaceutical development. [194][195][196][197][256]
  • 2026-05: AMA publishes updated survey data; OpenAI's blog separately cites the AMA 2026 survey at 72% of U.S. physicians using AI in clinical practice (up from 48% the prior year), with ASCO Post and LinkedIn Pulse providing secondary coverage establishing mainstream physician AI adoption as backdrop for the co-clinician's clinical trial phase. [94][96][97][5]
  • 2026-05: Medical Economics publishes analysis on AI malpractice law and physician disclosure obligations; MGMA publishes AI governance framework for medical group practices, adding practice management and legal practice voices to the governance discourse. [32][118]
  • 2026-05: NEJM AI publishes a pragmatic randomized controlled trial of ambient artificial intelligence, marking the first documented RCT-level evidence on ambient clinical AI in a top-tier medical journal. [29]
  • 2026-05: HealthManagement.org covers HealthBench as a healthcare AI evaluation framework, signaling the OpenAI-released benchmark is gaining traction in specialized healthcare media. [10]
  • 2026-08: (Upcoming) EU AI Act compliance deadline for medtech companies, including AI systems used as safety components in medical devices or direct patient-facing clinical roles — a binding regulatory forcing function for any clinical AI seeking EU market access. Multiple legal, consultancy, and healthcare-specific sources confirm the deadline with no public DeepMind statement on compliance posture; healthcare organizations face specific conformity assessment obligations under EU AI Act Annex III and Article 39. [149][151][153][154][155][156][157][158][24][25][26][27][28]

Perspectives

Google DeepMind / Google Research

Measured optimism with concrete deployment action: presents AI co-clinician as a research initiative with strong benchmark results, explicitly notes limitations, frames AI as operating under physician authority. The Included Health partnership, MedGemma 1.5 technical report (now at arXiv v4), and MedASR documentation signal active transition from research publication to structured clinical validation. The co-clinician is confirmed to outperform GPT-5.4 (base model) while trailing experienced physicians.

Evolution: Consistent: The Decoder's precise framing — 'beats GPT-5.4 in blind doctor tests but still trails experienced physicians' — sharpens the benchmark position; the GPT-5.4 comparison is specifically against the base model, not the ChatGPT for Clinicians workspace version that OpenAI claims outperforms physicians, leaving the ultimate performance comparison unresolved.

[1][34][35][36][37][38][39][40][3][41][42][43][44][4][45][46][47][48][2]

OpenAI

Active product competitor and self-appointed benchmark definer in clinical AI: ChatGPT for Clinicians is free to verified U.S. physicians and claims GPT-5.4 in the clinician workspace outperforms human physicians on HealthBench Professional — OpenAI's own open benchmark standard. The simultaneous release of the product and the evaluation framework positions OpenAI as the party setting the terms of comparison for the entire clinical AI field. HealthManagement.org's coverage of HealthBench as a healthcare AI evaluation framework signals the benchmark is gaining traction in healthcare-specific media.

Evolution: Updated: HealthManagement.org coverage of HealthBench (item 12190) provides additional evidence of the benchmark gaining healthcare media penetration beyond the initial launch, reinforcing OpenAI's structural position as the benchmark definer.

[5][6][8][7][9][49][50][10]

OpenEvidence

Dominant scaled competitor: a $12B valuation confirmed by Reuters, 1 million physician-AI consultations in a single 24-hour period, $210M in funding, and the launch of DeepConsult — 'the first AI agent purpose-built for physicians.' MedCity News published the first skeptical analytical take on the valuation, arguing it is unsurprising given adoption metrics rather than inflated.

Evolution: Consistent: no new OpenEvidence developments in current items.

[51][52][33][14][53][54][12][55][56][57][13][58][59][60][61][62][11]

Glass Health

Early-stage YC-backed competitor with $5M in funding, positioning in ambient scribing and clinical decision support — a scribing-first company that has entered the CDS comparison market and maintains a direct comparison page against Abridge. Its funding and scale are orders of magnitude below OpenEvidence, making it a niche rather than primary competitor to the co-clinician.

Evolution: Consistent: no new Glass Health developments in current items.

[63][64][65][66][67][68][69][70][57]

Abridge

Systematically expanding from AI scribe to evidence-backed clinical decision support: NEJM, JAMA, and UpToDate integrations embed clinical evidence directly into the EHR workflow, competing for institutional medical content authority rather than consumer physician adoption. Bakersfield.com AP wire confirms the NEJM/JAMA partnership has entered mainstream media circulation.

Evolution: Consistent: no new Abridge developments in current items.

[71][15][72][16][73][74][75][76][17][77][78]

Epic

EHR incumbent with a confirmed real-world AI agent deployment: Agent Factory was previewed at HIMSS26 as a no-code platform, and Advocate Health is documented as the first named health system adopter — converting the capability from announcement to deployment. MedCity News raises the 'readiness' question for health systems building their own agents, introducing the first critical framing of Agent Factory's deployment readiness.

Evolution: Consistent: no new Epic developments in current items.

[79][80][81][82][83][84][85][18][19]

JAMA / medical journal establishment

Institutionally engaged with the evidentiary question and commercially embedded in clinical AI deployment: JAMA continues calling for new AI research, publishing considerations on translating AI to improve care, and maintaining its commercial partnership with Abridge — making journals simultaneous validators, critics, and commercial participants. NEJM AI publishes the first documented pragmatic RCT of ambient AI, adding evidentiary weight to the ambient scribing category.

Evolution: Consistent: no new journal developments in current items.

[71][86][15][72][16][73][74][75][76][17][87][88][89][90][29]

American Medical Association (AMA)

Institutionally supportive of physician-led AI adoption: AMA 2026 survey cited by OpenAI shows 72% of U.S. physicians using AI in clinical practice (up from 48% the prior year); AMA's explicit position is that physicians must lead in developing AI tools. The 72% figure represents the most precisely sourced physician adoption data point in the thread.

Evolution: Consistent: no new AMA developments in current items.

[22][23][91][92][93][94][95][96][97][5]

American Board of Medical Specialties (ABMS)

Counter-perspective on AI and medical training: ABMS has published that AI may enhance rather than impair clinical skills and competence, directly opposing systematic review findings on AI-associated skill degradation and providing physician certification board credibility to the optimistic case for AI in medical training.

Evolution: Consistent: no new ABMS developments in current items.

[98]

Peterson Health Technology Institute (PHTI)

Health technology assessment voice focused on evidence and policy requirements before scaling clinical AI adoption — frames the question not as 'will AI help?' but as 'what evidence standard must be met before widespread deployment?', bridging outcomes research and policy. Multiple PHTI resource pages and workshop series confirm the institute's active ongoing focus on clinical AI assessment.

Evolution: Consistent: no new PHTI developments in current items.

[99][100][101][102][103][104][105][106][107]

ARISE / Stanford-Harvard institutional research

The ARISE organization (Artificial Intelligence Research Initiative in Safety and Effectiveness), led by Ethan Goh MD, is confirmed as the institutional home of the State of Clinical AI 2026 report. Goh's LinkedIn amplification of the ChatGPT for Clinicians launch places ARISE on record as tracking OpenAI's clinical entry as a significant market development.

Evolution: Consistent: no new ARISE developments in current items.

[108][109][110][111][112][113][114][115][116][117][49]

Medical Group Management Association (MGMA)

Governance voice focused on practice administration: MGMA frames AI in medical group practices as a governance challenge requiring rules 'for the humans in the loop' — a practice management framing distinct from both the AMA's physician-leadership stance and legal scholars' informed consent focus.

Evolution: Consistent: no new MGMA developments in current items.

[118]

Legal practice community (Medical Economics)

Clinically focused legal analysis: Medical Economics frames the AI disclosure question through malpractice liability — whether physicians have an obligation to disclose when AI is used in care — adding a clinical practice risk management angle beyond the academic frameworks of Stanford Law and Harvard Petrie-Flom.

Evolution: Consistent: no new Medical Economics developments in current items.

[32]

Microsoft

Competing in healthcare AI at global scale: published a healthcare AI transformation report on April 30, 2026 — the same day as DeepMind's co-clinician announcement — documenting AI progress for patients and medical professionals worldwide.

Evolution: Consistent: no new Microsoft developments in current items.

[119][120][21]

Amazon / incumbent tech competitors

Amazon has formally introduced the Amazon One Medical Health AI assistant and scaled a health AI assistant to all US customers.

Evolution: Consistent: no new Amazon developments in current items.

[121][122][123][124][125][126][127][128][20]

FDA (US regulatory)

Moving toward streamlined AI medical device approval: December 2024 finalization of simplified approval recommendations signals a forming regulatory pathway for clinical AI. The FDA's SaMD and AI-enabled device frameworks remain the applicable regime but have not been applied to conversational diagnostic AI specifically.

Evolution: Consistent: no new FDA developments in current items.

[129][130][131][132][133][134]

EU regulatory and legal analysts

Compliance-focused with a concrete August 2026 deadline now documented extensively across legal firms, healthcare consultancies, and regulatory guidance: EU AI Act Annex III high-risk classification applies to patient-facing clinical AI. Healthcare organizations face specific conformity assessment obligations under Article 39 before placing high-risk AI systems on the EU market. No public statement from DeepMind on EU compliance posture for the co-clinician.

Evolution: Updated: A new wave of EU AI Act compliance documentation (items 12184-12188) — spanning LinkedIn compliance analysis, McKenna Consultants' technical readiness guide, Tandem Health's healthcare-specific explainer, Mondaq's legal analysis for US companies, and the official EU AI Act Article 39 text — further confirms the August 2026 deadline and establishes specific conformity assessment pathways for healthcare organizations, deepening an already well-documented regulatory obligation.

[135][136][137][138][139][140][141][142][143][144][145][146][147][148][149][150][151][152][153][154][155][156][157][158][24][25][26][27][28]

Legal and bioethics scholars (Stanford Law CodeX, Harvard Petrie-Flom Center)

Critically constructive: Stanford Law argues existing disclosure frameworks fail on their own terms; Harvard Petrie-Flom Center argues AI and big data are redefining informed consent rules in ways existing frameworks have not accommodated.

Evolution: Consistent: no new legal/bioethics developments in current items.

[159][160][161][162][163][30][31]

Medical student community and medical education research

A growing and now formally contested research literature on medical student AI use: systematic reviews suggest AI adoption may impair clinical skill acquisition, while ABMS argues AI may enhance clinical skills, News Medical covers the critical thinking preservation challenge, CLIME and The Hospitalist address curriculum implications, and NEJM publishes on AI-enabled precision-education systems. The debate has moved from anecdotal Reddit concern to multi-institutional, multi-journal empirical dispute.

Evolution: Consistent: no new medical education AI developments in current items.

[164][165][166][167][168][169][170][171][172][173][174][175][176][177][178][98][179][90]

Technical AI trust research community

An arXiv preprint argues that clinical AI systems must move from opaque black-box confidence scores to measurable, auditable trust metrics — a technical governance challenge distinct from regulatory compliance or clinical validation, with direct implications for how benchmark results (including HealthBench Professional and DeepMind's own benchmarks) should be interpreted and what auditability means in practice.

Evolution: Consistent: no new technical trust research developments in current items.

[180]

Physician community (individual practitioners, LinkedIn, X/Twitter)

Early-adopter enthusiasm backed by majority adoption data: continued amplification across English and German platforms, with accounts linking the co-clinician to Google's drug discovery push approaching human trials. ARISE lead Ethan Goh separately amplifies the ChatGPT for Clinicians launch, signaling that the physician research community is tracking OpenAI's entry as a competing development.

Evolution: Consistent: no new physician community developments in current items.

[181][182][183][184][185][186][187][188][189][190][191][192][193][94][97][194][195][196][197][49]

AI medical scribe market (AWS HealthScribe, Nuance DAX, Freed, DeepCura, Clinically AI)

A mature, distinct market for documentation assistance AI operates in a separate category from diagnostic consultation AI, but Abridge's UpToDate partnership deepens its cross-over into evidence-backed decision support, blurring the category boundary. NEJM AI's pragmatic RCT of ambient AI adds evidentiary weight to the ambient scribing category.

Evolution: Consistent: no new ambient scribing market developments in current items.

[198][199][200][201][202][203][204][205][17][29]

Tensions

  • Incommensurable benchmark claims — co-clinician vs. ChatGPT for Clinicians: The Decoder documents DeepMind's co-clinician outperforming GPT-5.4 (base model) while trailing experienced physicians, while OpenAI claims GPT-5.4 in the ChatGPT for Clinicians workspace outperforms human physicians on HealthBench Professional. These claims use different evaluation frameworks, model versions, and physician comparison cohorts — making headline comparisons mutually inconsistent and unresolvable without independent adjudication on a shared benchmark. [2][5][6][7][48][1]
  • Benchmark definition as competitive advantage: OpenAI released HealthBench Professional as an open standard simultaneously with its product launch, positioning itself as the party setting evaluation terms for the clinical AI field. HealthManagement.org's coverage signals the benchmark is gaining healthcare media traction. If HealthBench Professional becomes an industry standard, DeepMind's co-clinician will be evaluated on OpenAI-defined criteria — a structural disadvantage regardless of underlying model performance. [5][6][7][1][180][10]
  • Benchmark performance vs. real-world clinical safety: the AI co-clinician achieved strong scores in controlled simulations — including reported outperformance of GPT-5.4 (base model) — but underperformed physicians specifically in identifying red flags and guiding physical examinations, the safety-critical skills most consequential in actual clinical settings. OpenAI's 99.6% safe-and-accurate rating is a physician-review metric, not a red-flag identification metric, making safety comparisons across systems currently impossible. [1][206][207][48][2][5]
  • Free-access consumer product vs. randomized trial design: OpenAI's ChatGPT for Clinicians is free to verified U.S. physicians today, while DeepMind's co-clinician is in the research-to-trial transition with the Included Health nationwide randomized study, and OpenEvidence has documented 1 million physician-AI clinical consultations in a 24-hour period. DeepMind's rigorous trial design may ultimately produce stronger evidentiary claims, but OpenAI and OpenEvidence accumulate real-world deployment scale and data in the meantime. [5][1][208][3][209][51][33][14][12][4][13][61][11]
  • AI and clinical skill development in trainees — competing empirical positions: previously documented systematic reviews suggest AI adoption during training may impair clinical skill acquisition and independent reasoning, while ABMS argues AI may enhance clinical skills and competence — the question has moved from an emerging concern to an actively contested empirical debate with institutional certification stakes on both sides. [165][167][168][169][170][164][174][175][178][98][179][90][1]
  • US vs. EU regulatory gap with a concrete and imminent deadline: FDA is moving toward simplified AI medical device approval but has not applied its framework to conversational diagnostic AI; the EU AI Act's August 2026 compliance deadline — now documented across legal firms, healthcare consultancies, and the official EU AI Act Article 39 text — creates a near-term forcing function Google has not publicly addressed, with healthcare organizations facing specific conformity assessment obligations before placing high-risk AI systems on the EU market. [210][211][212][213][214][149][151][130][131][132][133][152][153][154][155][156][157][158][24][25][26][27][28]
  • Patient transparency and consent — from academic frameworks to malpractice exposure: triadic care assumes patient awareness of AI involvement, but Stanford Law argues existing disclosure frameworks fail on their own terms, Harvard Petrie-Flom Center argues AI is redefining consent rules, and Medical Economics frames the question as active malpractice liability for practicing physicians — converting an academic debate into a clinical risk management question. [215][216][217][159][160][161][162][163][30][142][31][32]
  • Competitive differentiation in a converging market: Abridge's NEJM, JAMA, and UpToDate partnerships deepen its cross-over into consultation territory; OpenEvidence's DeepConsult mirrors DeepMind's physician-agent architecture at superior scale; OpenAI's ChatGPT for Clinicians is free to verified physicians with a physician-outperformance claim; Epic's Agent Factory has a named health-system adopter; and Glass Health competes with Abridge on scribing — DeepMind has not articulated what architecturally or clinically distinguishes the co-clinician from any of these competitors. [121][122][123][124][125][218][198][199][201][202][204][205][51][71][14][17][57][63][66][80][81][18][5]
  • Physician leadership vs. industry-led AI deployment: the AMA's position that 'physicians must lead in developing AI tools' and MGMA's 'rules for the humans in the loop' governance framing both sit in tension with a model where major tech companies (Google, OpenAI, Amazon, Microsoft, Epic) design the architecture, benchmarks, and deployment partnerships — with 72% physician AI adoption now mainstream, the governance question is who controls the design, including who defines evaluation standards. [22][23][93][1][40][94][119][21][118][5][6]
  • 'AI teammate' vs. 'AI doctor' branding: multiple social commentators analyze DeepMind's choice of 'co-clinician' over 'AI doctor' as a deliberate framing decision — raising the question of whether the naming obscures rather than resolves the autonomy questions at stake, particularly as OpenEvidence's DeepConsult operates at 1M-consultation scale and OpenAI claims physician-level or above performance without the same framing caution. [191][192][219][193][220][51][14][5]
  • 2026 as evidentiary inflection year: JAMA calls for new research on AI in medicine and has framed 2026 as potentially 'the year of real-world evidence,' while PHTI adds a policy layer — what evidence standard must be met before scaling adoption — and NEJM AI has published what appears to be the first pragmatic RCT of ambient AI. Ambient scribing now has RCT-level evidence; diagnostic consultation AI (including the co-clinician) remains in trial design phase. [51][71][86][3][108][4][110][221][115][88][89][99][29]
  • Same-day competitive narrative fragmentation: Microsoft's global healthcare AI report, Amazon's One Medical Health AI assistant launch, and OpenAI's ChatGPT for Clinicians (eight days prior) all appeared within a narrow window around DeepMind's co-clinician announcement — raising the question of whether DeepMind can establish distinctive narrative ownership in an environment where every major tech company is simultaneously announcing physician-facing healthcare AI products. [119][126][21][1][41][5]
  • Trust measurement gap in clinical AI: an arXiv preprint argues clinical AI systems must move from opaque black-box confidence scores to measurable, auditable trust metrics — a technical challenge that applies equally to OpenAI's HealthBench Professional (an open but self-defined standard) and to the co-clinician's published benchmarks, neither of which has operationally resolved what auditable clinical AI trust means in practice. [180][1][149][151][5][6]

Status: active but slowing

Sources

  1. [1] Enabling a new model for healthcare with AI co-clinician — DeepMind Blog (2026-04-30)
  2. [2] Google Deepmind's "AI co-clinician" beats GPT-5.4 in blind doctor tests but still trails experienced physicians — reactive:deepmind-ai-co-clinician
  3. [3] Collaborating on a nationwide randomized study of AI in real-world virtual care — reactive:deepmind-ai-co-clinician
  4. [4] In partnership with Included Health, we will be launching a first-of-its ... — reactive:deepmind-ai-co-clinician
  5. [5] Making ChatGPT better for clinicians — OpenAI Blog (2026-04-22)
  6. [6] HealthBench Professional: Evaluating Large Language Models on Real Clinician Chats — reactive:deepmind-ai-co-clinician
  7. [7] [PDF] HealthBench Professional: Evaluating Large Language Models on ... — reactive:deepmind-ai-co-clinician
  8. [8] OpenAI claims new ChatGPT model outperforms physicians on clinical tasks - Becker's Physician Leadership — reactive:deepmind-ai-co-clinician
  9. [9] GPT-5 outperformed doctors on the US medical licensing exam — reactive:deepmind-ai-co-clinician
  10. [10] Evaluating AI Models for Healthcare with HealthBench — reactive:deepmind-ai-co-clinician
  11. [11] Medical AI startup OpenEvidence doubles valuation to $12 billion in ... — reactive:deepmind-ai-co-clinician
  12. [12] OpenEvidence Achieves Historic Milestone: 1 Million Clinical ... — reactive:deepmind-ai-co-clinician
  13. [13] OpenEvidence Achieves Historic Milestone: 1 Million Clinical Consultations between Verified Doctors and an Artificial Intelligence System in a Single Day — reactive:deepmind-ai-co-clinician
  14. [14] OpenEvidence, the Fastest-Growing Application for Physicians in History, Announces $210 Million Round at $3.5 Billion Valuation: OpenEvidence also announces the wide release of OpenEvidence DeepConsult™—the first AI agent purpose-built for physicians | OpenEvidence — reactive:deepmind-ai-co-clinician
  15. [15] Abridge Integrates Peer-Reviewed Evidence with NEJM & JAMA — reactive:deepmind-ai-co-clinician
  16. [16] Abridge partners with medical journals to expand AI clinical decision support | Healthcare Dive — reactive:deepmind-ai-co-clinician
  17. [17] Abridge expands CDS with UpToDate, new content integrations — reactive:deepmind-ai-co-clinician
  18. [18] Advocate Health taps Epic's AI Agent Factory — reactive:deepmind-ai-co-clinician
  19. [19] At HIMSS26, Epic to highlight no-code Agent Factory and other AI advances | Healthcare IT News — reactive:deepmind-ai-co-clinician
  20. [20] Amazon launches healthcare AI assistant on its website, app - Reuters — reactive:deepmind-ai-co-clinician
  21. [21] AI Transformation Accelerates Progress in Healthcare Services for ... — reactive:deepmind-ai-co-clinician
  22. [22] AMA: Physicians' use of AI doubled from 2023 to 2026 — reactive:deepmind-ai-co-clinician
  23. [23] [PDF] 2026 Physician Survey on Augmented Intelligence — reactive:deepmind-ai-co-clinician
  24. [24] EU AI Act Conformity Assessment: What Providers Must Do Before ... — reactive:deepmind-ai-co-clinician
  25. [25] Prepare for EU AI Act High-Risk Obligations in 2026 — reactive:deepmind-ai-co-clinician
  26. [26] EU AI Act explained: what healthcare organisations need to know | Tandem Health — reactive:deepmind-ai-co-clinician
  27. [27] U.S. Companies Face EU AI Act's Possible August 2026 Compliance Deadline - New Technology - United States — reactive:deepmind-ai-co-clinician
  28. [28] Article 39: Conformity Assessment Bodies of Third Countries | EU Artificial Intelligence Act — reactive:deepmind-ai-co-clinician
  29. [29] A Pragmatic Randomized Controlled Trial of Ambient Artificial ... — reactive:deepmind-ai-co-clinician
  30. [30] Consent All the Way Down: What Healthcare AI Disclosure Inherits from Privacy Law - CodeX - Stanford Law School — reactive:deepmind-ai-co-clinician
  31. [31] Informed Consent, Redefined: How AI and Big Data Are Changing the Rules - Petrie-Flom Center — reactive:deepmind-ai-co-clinician
  32. [32] Inside AI malpractice law: Should physicians disclose when AI is used in care? | Medical Economics — reactive:deepmind-ai-co-clinician
  33. [33] OpenEvidence Doubles Valuation to $12bn as Physician Adoption Accelerates — reactive:deepmind-ai-co-clinician
  34. [34] researching the path toward AI-augmented care | Pushmeet Kohli — reactive:deepmind-ai-co-clinician
  35. [35] Google DeepMind AI coscientist system validated by lab experiments | Alan Karthikesalingam MD PhD posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  36. [36] Google Research Collaborates with DeepMind on Multi-Agent ... — reactive:deepmind-ai-co-clinician
  37. [37] Dr. Vivek Natarajan, Research Scientist at Google DeepMind/Health ... — reactive:deepmind-ai-co-clinician
  38. [38] Today, Google is announcing a strategic partnership with Included Health to collaborate on a nationwide randomized study of AI in virtual care. AI systems capable of clinical reasoning and dialogue… | Mike Schäkermann | 19 comments — reactive:deepmind-ai-co-clinician
  39. [39] Google Partnership to Pilot New Offering in Outpatient Care Setting | TechTarget — reactive:deepmind-ai-co-clinician
  40. [40] Enabling physician-centered oversight for AMIE - Google Research — reactive:deepmind-ai-co-clinician
  41. [41] AI co-clinician is our new research initiative to help explore how ... — reactive:deepmind-ai-co-clinician
  42. [42] Health AI — Google AI — reactive:deepmind-ai-co-clinician
  43. [43] MedGemma 1.5 Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  44. [44] Next generation medical image interpretation with MedGemma 1.5 and medical speech to text with MedASR — reactive:deepmind-ai-co-clinician
  45. [45] Enabling a new model for healthcare with AI co-clinician — reactive:deepmind-ai-co-clinician (2026-05-01)
  46. [46] MedGemma Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  47. [47] MedGemma: Our most capable open models for health AI development — reactive:deepmind-ai-co-clinician
  48. [48] Google DeepMind's AI co-clinician outpaces GPT-5.4, but doctors ... — reactive:deepmind-ai-co-clinician
  49. [49] ChatGPT for Clinicians Outperforms Physicians in New Study — reactive:deepmind-ai-co-clinician
  50. [50] OpenAI launches ChatGPT for Clinicians for medical notetaking — reactive:deepmind-ai-co-clinician
  51. [51] AI Collaborates with Physicians in 1M Clinical Consultations in 24 Hours | OpenEvidence posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  52. [52] AI Reshaping Clinical Decision-Making: OpenEvidence’s 2026 Strategic Outlook and Implications for the Greater Bay Area — reactive:deepmind-ai-co-clinician
  53. [53] The Clinical AI Landscape in 2026: ChatGPT, OpenEvidence, iatroX, Medwise, and What Comes Next | iatroX Clinical AI Insights — reactive:deepmind-ai-co-clinician
  54. [54] OpenEvidence Review — Clinical AI Report | Clinical AI Report — reactive:deepmind-ai-co-clinician
  55. [55] OpenEvidence revenue, valuation & funding - Sacra — reactive:deepmind-ai-co-clinician
  56. [56] How OpenEvidence AI is transforming clinical decision-making — reactive:deepmind-ai-co-clinician
  57. [57] OpenEvidence vs Glass Health: 2026 Comparison for Physicians | Clinical AI Report — reactive:deepmind-ai-co-clinician
  58. [58] Deep Consult | User Guide | OpenEvidence — reactive:deepmind-ai-co-clinician
  59. [59] OpenEvidence — reactive:deepmind-ai-co-clinician
  60. [60] Daniel Nadler on OpenEvidence: Doctors' Favorite AI App — reactive:deepmind-ai-co-clinician
  61. [61] OpenEvidence Achieves Historic Milestone: 1 Million Clinical ... — reactive:deepmind-ai-co-clinician
  62. [62] Thunderstruck By OpenEvidence’s $12B Valuation? Don’t Be.  - MedCity News — reactive:deepmind-ai-co-clinician
  63. [63] Glass Health Review — Clinical AI Report | Clinical AI Report — reactive:deepmind-ai-co-clinician
  64. [64] Glass Health Raises $5M for AI-Powered Clinical Decision Support Platform | Y Combinator | 13 comments — reactive:deepmind-ai-co-clinician
  65. [65] Glass Health - 2026 Company Profile, Team, Funding & Competitors — reactive:deepmind-ai-co-clinician
  66. [66] Glass Health vs Abridge AI: 2026 Scribe & CDS Comparison — reactive:deepmind-ai-co-clinician
  67. [67] Glass Health 2026 Company Profile: Valuation, Funding & Investors — reactive:deepmind-ai-co-clinician
  68. [68] Glass Health: AI-Powered Clinical Decision Support Company ... — reactive:deepmind-ai-co-clinician
  69. [69] Glass Health | Ambient Scribing & Clinical Decision Support — reactive:deepmind-ai-co-clinician
  70. [70] Glass Health: AI-Powered Clinical Decision Support & Ambient Scribing | Y Combinator — reactive:deepmind-ai-co-clinician
  71. [71] Abridge Partners with NEJM and JAMA for AI Clinical Decision-Making — reactive:deepmind-ai-co-clinician
  72. [72] Why Abridge is Embedding NEJM and JAMA Directly into the EHR — reactive:deepmind-ai-co-clinician
  73. [73] Abridge incorporates more clinical evidence into its decision support tools | Healthcare IT News — reactive:deepmind-ai-co-clinician
  74. [74] Partnership for clinical decision support moves AI to next level — reactive:deepmind-ai-co-clinician
  75. [75] Abridge to Bring NEJM & JAMA into Clinical Conversations — reactive:deepmind-ai-co-clinician
  76. [76] Abridge Partners with NEJM and JAMA to Integrate Peer-Reviewed ... — reactive:deepmind-ai-co-clinician
  77. [77] Abridge Clinical Decision Support | Evidence Shaped by Your Conversation — reactive:deepmind-ai-co-clinician
  78. [78] Abridge Partners with NEJM and JAMA to Integrate Peer-Reviewed Evidence Shaped by Clinical Conversations — reactive:deepmind-ai-co-clinician
  79. [79] Epic Releases Native AI Charting for Integrated Clinical ... - HLTH — reactive:deepmind-ai-co-clinician
  80. [80] Epic Unveils Agent Factory & Expands ... — reactive:deepmind-ai-co-clinician
  81. [81] Epic Is Letting Health Systems Build Their Own Agents — But Are They Ready? - MedCity News — reactive:deepmind-ai-co-clinician
  82. [82] Epic previews Agent Factory AI platform at HIMSS26. — reactive:deepmind-ai-co-clinician
  83. [83] Epic's Agent Factory: The Platform Is Real. Your next move is important — reactive:deepmind-ai-co-clinician
  84. [84] #digitalhealth #ai | Gary Monk — reactive:deepmind-ai-co-clinician
  85. [85] HIMSS26: Epic expands AI road map, touts key outcome metrics — reactive:deepmind-ai-co-clinician
  86. [86] Will 2026 be the year of real-world evidence that #AI can actually ... — reactive:deepmind-ai-co-clinician
  87. [87] Considerations in Translating AI to Improve Care - JAMA Network — reactive:deepmind-ai-co-clinician
  88. [88] JAMA — reactive:deepmind-ai-co-clinician
  89. [89] AI, Health, and Health Care Today and Tomorrow - JAMA Network — reactive:deepmind-ai-co-clinician
  90. [90] AI-Enabled Precision-Education Systems — Transforming Lifelong ... — reactive:deepmind-ai-co-clinician
  91. [91] Feb. 27, 2026: National Advocacy Update — reactive:deepmind-ai-co-clinician
  92. [92] Physician Survey on Augmented Intelligence | American Medical Association — reactive:deepmind-ai-co-clinician
  93. [93] AMA: Physicians must lead in developing AI tools to improve patient ... — reactive:deepmind-ai-co-clinician
  94. [94] More than 80% of physicians use AI professionally: AMA survey | American Medical Association — reactive:deepmind-ai-co-clinician
  95. [95] AI, Health Care, and What to Expect in 2026 - AMA Ed Hub — reactive:deepmind-ai-co-clinician
  96. [96] AMA Survey Finds Rapid Growth in Physician AI Adoption - The ASCO Post — reactive:deepmind-ai-co-clinician
  97. [97] AI in medicine is moving fast—and physicians are already putting it ... — reactive:deepmind-ai-co-clinician
  98. [98] AI May Enhance Clinical Skills, Competence | American Board of Medical Specialties — reactive:deepmind-ai-co-clinician
  99. [99] Clinical AI: Evidence and Policy Requirements for Scaling Adoption — reactive:deepmind-ai-co-clinician
  100. [100] Best Practices Archives | Peterson Health Technology Institute — reactive:deepmind-ai-co-clinician
  101. [101] Regulatory Archives | Peterson Health Technology Institute — reactive:deepmind-ai-co-clinician
  102. [102] [PDF] PHTI-Clinical-AI-Evidence-and-Policy-Requirements-for-Scaling ... — reactive:deepmind-ai-co-clinician
  103. [103] Letter to HHS on Use of Artificial Intelligence as Part of Clinical Care — reactive:deepmind-ai-co-clinician
  104. [104] Research & Insights — reactive:deepmind-ai-co-clinician
  105. [105] Peterson Health Technology Institute Releases New Digital Health Assessment Framework — reactive:deepmind-ai-co-clinician
  106. [106] Duncan Greenberg's Post - LinkedIn — reactive:deepmind-ai-co-clinician
  107. [107] AI Applications in Healthcare Workshop Series | Peterson Health Technology Institute — reactive:deepmind-ai-co-clinician
  108. [108] Clinical AI Has Boomed. A New Stanford-Harvard State of Clinical AI ... — reactive:deepmind-ai-co-clinician
  109. [109] Stanford-Harvard Report on Clinical AI in 2026 | Moritz Hartmann posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  110. [110] State of Clinical AI Report 2026 - ARISE — reactive:deepmind-ai-co-clinician
  111. [111] Clinical AI Enters a New Phase, Stanford–Harvard Report Finds - BABL AI — reactive:deepmind-ai-co-clinician
  112. [112] [PDF] State of Clinical AI Report 2026 - Public Services Alliance — reactive:deepmind-ai-co-clinician
  113. [113] Dr Lucinda Scharff's Post - State of Clinical AI Report 2026 - LinkedIn — reactive:deepmind-ai-co-clinician
  114. [114] Jonas Verbeke - State of Clinical AI Report 2026 - LinkedIn — reactive:deepmind-ai-co-clinician
  115. [115] Medicine | The 2026 AI Index Report | Stanford HAI — reactive:deepmind-ai-co-clinician
  116. [116] ARISE Releases 2026 State of Clinical AI Report | Ethan Goh, MD posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  117. [117] ARISE Maps the State of Clinical AI — reactive:deepmind-ai-co-clinician
  118. [118] AI governance in medical group practices: Rules for the humans in the loop — reactive:deepmind-ai-co-clinician
  119. [119] Big Tech Enters Healthcare with Amazon Health, Microsoft Copilot ... — reactive:deepmind-ai-co-clinician
  120. [120] AI Solutions Optimized for Epic | Microsoft for Healthcare — reactive:deepmind-ai-co-clinician
  121. [121] Randomized Trial Protocol: Epic Generative AI Chart Summarization Tool to Reduce Ambulatory Provider Cognitive Task Load | medRxiv — reactive:deepmind-ai-co-clinician
  122. [122] Amazon's Healthcare AI vs. Everyone Else: Who Will Own the Doctor's Office in 2026? | AI Magicx Blog | AI Magicx — reactive:deepmind-ai-co-clinician
  123. [123] Epic AI Charting 2026: What Healthcare Providers Need to Know | SOAPNoteAI - SOAP Note Guides and Examples — reactive:deepmind-ai-co-clinician
  124. [124] Amazon makes a new bet on healthcare AI, rivaling Microsoft in the doctor's office – GeekWire — reactive:deepmind-ai-co-clinician
  125. [125] Amazon Scales Health AI Assistant to All US Customers — reactive:deepmind-ai-co-clinician
  126. [126] Today, we're excited to introduce the new Amazon One Medical ... — reactive:deepmind-ai-co-clinician
  127. [127] Epic's AI Scribe: Impact on Ambient Market and Predictions | Joshua Liu posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  128. [128] Amazon's move to get out ahead in health AI agent race — reactive:deepmind-ai-co-clinician
  129. [129] FDA Approval of Artificial Intelligence and Machine Learning ... - PMC — reactive:deepmind-ai-co-clinician
  130. [130] FDA finalizes recommendations simplifying approval process for medical devices that use AI | AHA News — reactive:deepmind-ai-co-clinician
  131. [131] Artificial Intelligence in Clinical Decision-Making: Regulatory Roadmap and Reimbursement Strategies | Akin Gump Strauss Hauer & Feld LLP - JDSupra — reactive:deepmind-ai-co-clinician
  132. [132] Artificial Intelligence in Software as a Medical Device - FDA — reactive:deepmind-ai-co-clinician
  133. [133] Artificial Intelligence-Enabled Medical Devices - FDA — reactive:deepmind-ai-co-clinician
  134. [134] Considerations for the Use of Artificial Intelligence - FDA — reactive:deepmind-ai-co-clinician
  135. [135] Journal of Medical Internet Research - AI Act Compliance Within the MyHealth@EU Framework: Tutorial — reactive:deepmind-ai-co-clinician
  136. [136] European Commission consultation shapes high-risk AI classification for life sciences in the EU | Osborne Clarke — reactive:deepmind-ai-co-clinician
  137. [137] Balancing Innovation and Control: The European Union AI Act ... — reactive:deepmind-ai-co-clinician
  138. [138] The EU AI Act & Pharma: Compliance Guide + Flowchart | IntuitionLabs — reactive:deepmind-ai-co-clinician
  139. [139] EU Commission Consultation on High-Risk AI Systems — reactive:deepmind-ai-co-clinician
  140. [140] AI in Clinical Trials & Compliance with the EU AI Act — reactive:deepmind-ai-co-clinician
  141. [141] Artificial Intelligence in healthcare — reactive:deepmind-ai-co-clinician
  142. [142] Article 6: Classification Rules for High-Risk AI Systems | EU Artificial Intelligence Act — reactive:deepmind-ai-co-clinician
  143. [143] Annex III: High-Risk AI Systems Referred to in Article 6(2) - EU AI Act — reactive:deepmind-ai-co-clinician
  144. [144] How the EU AI Act Affects Clinical Trials — reactive:deepmind-ai-co-clinician
  145. [145] EU AI Act Compliance: Annex III Extension Guide 2024 — reactive:deepmind-ai-co-clinician
  146. [146] EU AI Act for Medical Devices: SaMD Compliance ... - MDx CRO — reactive:deepmind-ai-co-clinician
  147. [147] High-Risk AI Systems Under the EU AI Act - DPO Consulting — reactive:deepmind-ai-co-clinician
  148. [148] High-Risk AI Systems: Strict Compliance Obligations You Need to ... — reactive:deepmind-ai-co-clinician
  149. [149] EU AI Act and Medical Devices: Compliance Guide 2026 — reactive:deepmind-ai-co-clinician
  150. [150] [PDF] Conformity Assessments under the EU AI Act: A step-by step guide — reactive:deepmind-ai-co-clinician
  151. [151] Implementation Timeline | EU Artificial Intelligence Act — reactive:deepmind-ai-co-clinician
  152. [152] The EU AI Act in Healthcare: From compliance to competitive edge — reactive:deepmind-ai-co-clinician
  153. [153] EU AI Act – What are the obligations for “high-risk AI systems”? — reactive:deepmind-ai-co-clinician
  154. [154] Complete Guide to EU AI Act High-Risk Classification | EU AI Act Resources | EU AI Risk — reactive:deepmind-ai-co-clinician
  155. [155] High-Risk AI System Requirements: Complete Compliance Guide ... — reactive:deepmind-ai-co-clinician
  156. [156] EU AI Act High-Risk Deadline: Enterprise Readiness Gap - Lab Space — reactive:deepmind-ai-co-clinician
  157. [157] EU AI Act Compliance Deadline: 123 Days Away for High-Risk ... — reactive:deepmind-ai-co-clinician
  158. [158] The EU AI Act officially entered into force! What are the compliance ... — reactive:deepmind-ai-co-clinician
  159. [159] The Emerging Therapeutic Triad: How AI Complicates Informed ... — reactive:deepmind-ai-co-clinician
  160. [160] Artificial intelligence and the law of informed consent - Research Handbook on Health, AI and the Law - NCBI Bookshelf — reactive:deepmind-ai-co-clinician
  161. [161] The use of #AI tools in health care raises questions about patient ... — reactive:deepmind-ai-co-clinician
  162. [162] Patient Consent and The Right to Notice and Explanation of AI ... — reactive:deepmind-ai-co-clinician
  163. [163] Notification and Consent Preferences Based on U.S. National Survey — reactive:deepmind-ai-co-clinician
  164. [164] Google DeepMind AI co-clinician : r/medicalschool - Reddit — reactive:deepmind-ai-co-clinician
  165. [165] Utilization of AI Among Medical Students and Development of AI ... — reactive:deepmind-ai-co-clinician
  166. [166] How Medical Teaching Will Look in 2026 with AI Driven Platforms — reactive:deepmind-ai-co-clinician
  167. [167] Medical students perceptions and attitudes toward the use of ... — reactive:deepmind-ai-co-clinician
  168. [168] AI Use for Medical Students: Impact on Clinical Skill Acquisition and ... — reactive:deepmind-ai-co-clinician
  169. [169] Attitudes of medical and life sciences university students ... - Nature — reactive:deepmind-ai-co-clinician
  170. [170] AI Use for Medical Students: Impact on Clinical Skill Acquisition and ... — reactive:deepmind-ai-co-clinician
  171. [171] [PDF] Awareness and Attitude Toward Artificial Intelligence Among ... — reactive:deepmind-ai-co-clinician
  172. [172] Integrating artificial intelligence into medical education: a roadmap ... — reactive:deepmind-ai-co-clinician
  173. [173] Why AI in Medical Education Needs a 2026 Strategy — reactive:deepmind-ai-co-clinician
  174. [174] AI in medical student education | AMEP | Dove Medical Press — reactive:deepmind-ai-co-clinician
  175. [175] AI Use for Medical Students: Impact on Clinical Skill Acquisition and ... — reactive:deepmind-ai-co-clinician
  176. [176] Artificial intelligence in medicine: a scoping review of the risk of ... — reactive:deepmind-ai-co-clinician
  177. [177] Opportunities and Risks of AI for Precision Medical Education - CLIME — reactive:deepmind-ai-co-clinician
  178. [178] How can medical trainees use AI without losing critical thinking skills? — reactive:deepmind-ai-co-clinician
  179. [179] Curriculum and Educational Implications of AI - The Hospitalist — reactive:deepmind-ai-co-clinician
  180. [180] From Black-Box Confidence to Measurable Trust in Clinical AI - arXiv — reactive:deepmind-ai-co-clinician
  181. [181] Google DeepMind Launches AI Co-Clinician - YouTube — reactive:deepmind-ai-co-clinician
  182. [182] Big week for AI: 🤖 — reactive:deepmind-ai-co-clinician (2026-05-02)
  183. [183] 🩺 Doctor + AI + Patient — reactive:deepmind-ai-co-clinician (2026-05-01)
  184. [184] Alan takes a deep dive into this remarkable new AI co-clinician from Google DeepMind. — reactive:deepmind-ai-co-clinician (2026-05-01)
  185. [185] Google DeepMind's AI co-clinician research is a reminder that the next healthcare AI wave may not replace doctors. It ma... — reactive:deepmind-ai-co-clinician (2026-05-01)
  186. [186] OpenAI introduces Advanced Account Security, DeepMind AI co-clinician | Next in AI | Astha La Vista #ai #artificialint... — reactive:deepmind-ai-co-clinician (2026-05-01)
  187. [187] AI News – May 1, 2026 — reactive:deepmind-ai-co-clinician (2026-05-01)
  188. [188] Google DeepMind's AI clinician aims to aid doctors | StartupHub.ai — reactive:deepmind-ai-co-clinician
  189. [189] AI co-clinician is our new research initiative to help explore how ... — reactive:deepmind-ai-co-clinician
  190. [190] AI co-clinician: enabling a new model for healthcare | Vishnu Ravi, MD — reactive:deepmind-ai-co-clinician
  191. [191] Google DeepMind isn’t building an AI doctor — it’s giving doctors an AI teammate. — reactive:deepmind-ai-co-clinician (2026-05-01)
  192. [192] Google DeepMind chamou de "co-clinician", não de "AI doctor" ou "diagnostic agent". — reactive:deepmind-ai-co-clinician (2026-05-01)
  193. [193] Google DeepMind's AI co-clinician runs live video with patients, guides physical exams in real time, and defers to physi... — reactive:deepmind-ai-co-clinician (2026-05-01)
  194. [194] AI co-clinician: researching the path toward AI-augmented care | Google DeepMind — reactive:deepmind-ai-co-clinician (2026-05-02)
  195. [195] https://t.co/JarrlxEhJ6 — reactive:deepmind-ai-co-clinician (2026-05-02)
  196. [196] #TECH: 🌐Google DeepMind Unveils AI Co Clinician as Drug Discovery Push Nears Human Trials — reactive:deepmind-ai-co-clinician (2026-05-02)
  197. [197] DeepMind bringt 'AI co‑clinician': KI hilft dir und Ärzt:innen in Praxis & Telemedizin, bleibt Assistenz — Blindtest... — reactive:deepmind-ai-co-clinician (2026-05-02)
  198. [198] Compare AWS HealthScribe vs. Clinically AI in 2026 — reactive:deepmind-ai-co-clinician
  199. [199] 2026 AI Medical Scribe Comparison: Top Tools for Clinicians | Twofold Health posted on the topic | LinkedIn — reactive:deepmind-ai-co-clinician
  200. [200] Healthcare AI Platforms: AWS vs Microsoft vs Google 2026 — reactive:deepmind-ai-co-clinician
  201. [201] Top AI Medical Scribe Companies in 2026 | Accuracy & Comparison — reactive:deepmind-ai-co-clinician
  202. [202] 15 Best AI Medical Scribes in 2026 (Ranked & Compared) - DeepCura — reactive:deepmind-ai-co-clinician
  203. [203] AWS HealthScribe vs. Clinically AI Comparison - SourceForge — reactive:deepmind-ai-co-clinician
  204. [204] 9 Best AI Scribes [2026] Comparisons, Benefits, Features, and More — reactive:deepmind-ai-co-clinician
  205. [205] 5 Best AI Medical Scribe Tools for 2026: In-Depth Comparison - Reddit — reactive:deepmind-ai-co-clinician
  206. [206] Google DeepMind’s real-time video AI doctor is here. — Rohan Paul Twitter (2026-04-30)
  207. [207] 🔴 DeepMind AI co-clinician: 98 blind-eval queries — doctors preferred it. 97/98 zero critical errors. — reactive:deepmind-ai-co-clinician (2026-05-01)
  208. [208] Google to evaluate conversational AI in virtual care — reactive:deepmind-ai-co-clinician
  209. [209] Google Research Partners with Included Health on Nationwide AI ... — reactive:deepmind-ai-co-clinician
  210. [210] Understanding FDA regulations for AI in SaMD | ICON plc — reactive:deepmind-ai-co-clinician
  211. [211] FDA Clearance & Clinical Adoption for AI Diagnostics | Bot Image — reactive:deepmind-ai-co-clinician
  212. [212] AI for Medical Device Regulation (FDA): Accelerating Approval Pathways - PPLE Labs — reactive:deepmind-ai-co-clinician
  213. [213] Demystifying Regulatory Hurdles: How to Navigate FDA Approval for ... — reactive:deepmind-ai-co-clinician
  214. [214] How to Get your AI models FDA approved: AI/ML Regulatory Landscape | Encord — reactive:deepmind-ai-co-clinician
  215. [215] 66% of US doctors now use AI in your care — often without saying ... — reactive:deepmind-ai-co-clinician
  216. [216] When AI is in the room: rethinking the medical conversation | InSight+ — reactive:deepmind-ai-co-clinician
  217. [217] AI is a 'third party' in the consultation room, say experts - BMJ Group — reactive:deepmind-ai-co-clinician
  218. [218] AI co-clinician from DeepMind will start a new product war provoking OpenEvidence, DoximityGPT, ChatGPT for Clinicians, ... — reactive:deepmind-ai-co-clinician (2026-05-01)
  219. [219] Google Deepmind just announced an AI that sits in the exam room with your doctor. — reactive:deepmind-ai-co-clinician (2026-05-01)
  220. [220] 醫院 AI 不再叫「工具」，改名「聯合醫師」。 — reactive:deepmind-ai-co-clinician (2026-05-01)
  221. [221] The 2026 AI Index Report | Stanford HAI — reactive:deepmind-ai-co-clinician
  222. [222] AI assistant for doctors? Google DeepMind working on AI model that ... — reactive:deepmind-ai-co-clinician
  223. [223] MedGemma 1.5 model card | Health AI Developer Foundations — reactive:deepmind-ai-co-clinician
  224. [224] MedGemma 1.5: Mastering 3D Medical Imaging and EHR Analysis — reactive:deepmind-ai-co-clinician
  225. [225] [2604.05081] MedGemma 1.5 Technical Report - arXiv — reactive:deepmind-ai-co-clinician
  226. [226] (PDF) MedGemma 1.5 Technical Report - ResearchGate — reactive:deepmind-ai-co-clinician
  227. [227] MedGemma 1.5: Run Medical AI on Your Own Servers - medgemma.pro — reactive:deepmind-ai-co-clinician
  228. [228] MedGemma 1.5 Extends Google's Open Model for Healthcare AI ... — reactive:deepmind-ai-co-clinician
  229. [229] MedGemma: Advanced AI Models for Medical Text and Image ... — reactive:deepmind-ai-co-clinician
  230. [230] UNN 127: Google's MedGemma AI Can Now Read CT & MRI Scans — reactive:deepmind-ai-co-clinician
  231. [231] AI for Doctors: MedGemma Reads Scans, MedASR Writes It Down — reactive:deepmind-ai-co-clinician
  232. [232] Revolutionizing Healthcare: How Google DeepMind is Transforming ... — reactive:deepmind-ai-co-clinician
  233. [233] Google DeepMind launches AI co-clinician research program with multimodal AI agent | KuCoin — reactive:deepmind-ai-co-clinician
  234. [234] Google DeepMind Launches AI Co-Clinician Initiative — reactive:deepmind-ai-co-clinician
  235. [235] Google Deepmind launches AI Co-Clinician initiative - Reddit — reactive:deepmind-ai-co-clinician
  236. [236] Wow, this is so cool! Real-time AI doctor, via video, from Google ... — reactive:deepmind-ai-co-clinician
  237. [237] Google DeepMind deklassiert mit dem AI co-clinician GPT-5.4 im Medizin-Benchmark. Ein multimodales KI-Modell für Live-Te... — reactive:deepmind-ai-co-clinician (2026-04-30)
  238. [238] @AudioBooksRU @GoogleDeepMind @harvardmed @StanfordMed You're right—the demo shows the AI co-clinician directly intervie... — reactive:deepmind-ai-co-clinician (2026-04-30)
  239. [239] AI co-clinician: researching the path toward AI-augmented care — Google DeepMind https://t.co/6qXLmCd8Av — reactive:deepmind-ai-co-clinician (2026-04-30)
  240. [240] AI co-clinician: researching the path toward AI-augmented care - Google DeepMind https://t.co/JA2TobQ7jS — reactive:deepmind-ai-co-clinician (2026-04-30)
  241. [241] This AI co-clinician from Google DeepMind aced 97 out of 98 clinical tests — reactive:deepmind-ai-co-clinician (2026-04-30)
  242. [242] Google DeepMindが『AI co-clinician』を発表。マルチモーダルエージェントが医療現場をサポート。医療従事者とAIの協働で課題解決へ。ぼくも注視中。 by トウマ — reactive:deepmind-ai-co-clinician (2026-04-30)
  243. [243] Google DeepMind、医師を支援する AI co-clinician を発表🏥🤖 臨床エビデンス統合で 98 件中 97 件を正確に処理。テレメディシンでは一次医療医と同等のパフォーマンス。WHO が指摘する医療労働者 1000 ... — reactive:deepmind-ai-co-clinician (2026-04-30)
  244. [244] Excited to see DeepMind's AI co‑clinician initiative advancing multimodal support. To deliver value on healthcare teams... — reactive:deepmind-ai-co-clinician (2026-04-30)
  245. [245] NEWS: Google DeepMind announces AI co-clinician for healthcare. — reactive:deepmind-ai-co-clinician (2026-04-30)
  246. [246] Google Deepmind dropped ai co clinician research today — reactive:deepmind-ai-co-clinician (2026-04-30)
  247. [247] Google DeepMind unveils AI co-clinician. — reactive:deepmind-ai-co-clinician (2026-04-30)
  248. [248] NEWS: Google DeepMind launches an AI co-clinician research project to explore how multimodal agents can assist healthcar... — reactive:deepmind-ai-co-clinician (2026-04-30)
  249. [249] Google DeepMind just dropped an AI co-clinician 🤖 — reactive:deepmind-ai-co-clinician (2026-04-30)
  250. [250] Google DeepMind Just Solved a Major Problem with AI Doctors — reactive:deepmind-ai-co-clinician
  251. [251] 2026年4月30日、Google DeepMindが「AI co-clinician: researching the path toward AI-augmented care」を公開しました。臨床推論や診療判断を補助するAI共同臨床医... — reactive:deepmind-ai-co-clinician (2026-04-30)
  252. [252] BREAKING: google deepmind publishes research on an ai co-clinician model for healthcare. https://t.co/8uNF4AewKw — reactive:deepmind-ai-co-clinician (2026-04-30)
  253. [253] AI co-clinician is Google DeepMind's new research initiative to help ... — reactive:deepmind-ai-co-clinician
  254. [254] Google Partners with Included Health on Nationwide AI in Virtual ... — reactive:deepmind-ai-co-clinician
  255. [255] الوضع صار اكثر جديه الان وممتع 😅 — reactive:deepmind-ai-co-clinician (2026-05-01)
  256. [256] Google DeepMind's AI co-clinician research is another signal that ... — reactive:deepmind-ai-co-clinician